Literature DB >> 36228264

Changes in the frequency and clinical features of acute rheumatic fever in the COVID-19 era: a retrospective analysis from a single center.

Fuat Laloğlu1, Naci Ceviz1.   

Abstract

OBJECTIVE: Coronavirus disease 2019 (COVID-19) pandemic resulted in significant changes in the frequency of many diseases. In this study, we aimed to investigate the changes in the frequency and clinical features of acute rheumatic fever (ARF) in this period and determine the effect of health measures taken against COVID-19 on this change.
METHODS: The cases with initial attack of ARF between January 2016 and March 2022 in Ataturk University, Division of Pediatric Cardiology, were determined from the clinic's database, and case per month ratios were calculated for each period, retrospectively. Also the frequency of the clinical manifestations was compared among patients before and during the outbreak.
RESULTS: Frequency of the major clinical manifestations among patients before and during the outbreak was similar. On average, the number of cases reported per month in the years 2016, 2017, 2018, and 2019 are, respectively, 1.75, 2, 2.25, and 2.58. In the first 3 months of 2020, the average number of cases reported per month was 3.67. After the advent of the pandemic, in the period from April to December 2020 and from January to September 2021, an average of 0.56 and 0.22 cases were reported per month, respectively. The frequency of clinical features between patients diagnosed before and during the outbreak was similar.
CONCLUSIONS: Our results indicated an important decrease in frequency of ARF, but no change in the clinical features of the disease during the COVID-19 pandemic. It is thought that this is the result of health measures taken for COVID-19. Children with an increased risk of acute rheumatic fever should be encouraged in terms of wearing mask, social distance, and cleaning, especially during the seasons when upper respiratory tract infections are common. Thus, a permanent decrease in the incidence of ARF and its recurrences may be achieved.

Entities:  

Mesh:

Year:  2022        PMID: 36228264      PMCID: PMC9575005          DOI: 10.1590/1806-9282.20220620

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.712


  15 in total

1.  Rheumatic heart disease prevalence among schoolchildren in Ankara, Turkey.

Authors:  R Olguntürk; G B Aydin; F S Tunaoğlu; N Akalin
Journal:  Turk J Pediatr       Date:  1999 Apr-Jun       Impact factor: 0.552

2.  Rheumatic fever and social justice.

Authors:  Alex Brown; Malcolm I McDonald; Tom Calma
Journal:  Med J Aust       Date:  2007-06-04       Impact factor: 7.738

3.  Echocardiographic screening for rheumatic heart disease in Turkish schoolchildren.

Authors:  Semra Atalay; Ercan Tutar; Tayfun Uçar; Seda Topçu; Serdal K Köse; Melih T Doğan
Journal:  Cardiol Young       Date:  2019-09-02       Impact factor: 1.093

4.  COVID-19 optimal vaccination policies: A modeling study on efficacy, natural and vaccine-induced immunity responses.

Authors:  Manuel Adrian Acuña-Zegarra; Saúl Díaz-Infante; David Baca-Carrasco; Daniel Olmos Liceaga
Journal:  Math Biosci       Date:  2021-05-04       Impact factor: 2.144

5.  Incidence and clinical characteristics of acute rheumatic fever in Turkey: Results of a nationwide multicentre study.

Authors:  Dolunay Gürses; Gülendam Koçak; Ercan Tutar; Nazan Özbarlas
Journal:  J Paediatr Child Health       Date:  2021-07-06       Impact factor: 1.954

6.  Decreased Influenza Incidence under COVID-19 Control Measures, Singapore.

Authors:  Roy Jiunn Jye Soo; Calvin J Chiew; Stefan Ma; Rachael Pung; Vernon Lee
Journal:  Emerg Infect Dis       Date:  2020-04-27       Impact factor: 6.883

Review 7.  The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: A systematic review.

Authors:  Pasqualina M Coffey; Anna P Ralph; Vicki L Krause
Journal:  PLoS Negl Trop Dis       Date:  2018-06-13

8.  Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases.

Authors:  Ummusen Kaya Akca; Erdal Atalay; Muserref Kasap Cuceoglu; Zeynep Balik; Seher Sener; Yasemin Ozsurekci; Ozge Basaran; Ezgi Deniz Batu; Yelda Bilginer; Seza Ozen
Journal:  Rheumatol Int       Date:  2021-11-02       Impact factor: 2.631

9.  Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.

Authors:  Vladislav Vukomanovic; Stasa Krasic; Sergej Prijic; Sanja Ninic; Sasa Popovic; Gordana Petrovic; Snezana Ristic; Radoje Simic; Ivana Cerovic; Dejan Nesic
Journal:  Pediatr Infect Dis J       Date:  2021-11-01       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.